Evan A. Thackaberry
Corporate Officer/Principal bij VIGIL NEUROSCIENCE, INC.
Vermogen: 4 770 $ op 31-05-2024
Actieve functies van Evan A. Thackaberry
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| VIGIL NEUROSCIENCE, INC. | Corporate Officer/Principal | 01-09-2020 | - |
Loopbaan van Evan A. Thackaberry
Eerdere bekende functies van Evan A. Thackaberry
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| RA PHARMACEUTICALS, INC. | Corporate Officer/Principal | 01-10-2017 | 01-03-2020 |
Opleiding van Evan A. Thackaberry
| University of Wisconsin | Doctorate Degree |
Statistieken
Internationaal
| Verenigde Staten | 4 |
Operationeel
| Corporate Officer/Principal | 2 |
| Doctorate Degree | 1 |
Sectoraal
| Health Technology | 3 |
| Consumer Services | 2 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| VIGIL NEUROSCIENCE, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Ra Pharmaceuticals, Inc.
 Ra Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Ra Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in the discovery and development of peptide-based drugs. It uses Extreme Diversity platform that allows to produce synthetic macrocyclic peptides. The company was founded by James W. Broderick and Douglas A. Treco on June 27, 2008 and is headquartered in Cambridge, MA. | Health Technology |
- Beurs
- Insiders
- Evan A. Thackaberry
- Ervaring
